website-header.png

Uniform Clinical Trials Protocol

Year: 
2013 to 2014
NAAF Requested Research Grant Opportunities
James A. Solomon, MD, PhD, Principal Investigator
Ameriderm Research

Develop the initial core Uniform Alopecia Areata Clinical Trials Protocol, a standardized protocol for future studies. 

Significance

Defining meaningful inclusion and exclusion criteria, safety and efficacy end-points, dosing algorithms and patient outcome measures to reduce the burden on researchers and improve comparison across studies.

Purpose

A preapproved published protocol template advances clinical studies, and enables us to judge the effectiveness of therapies and compare one study to another. There will be no need for individual investigators to duplicate efforts.